Opportunity ID: 320079

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-358
Funding Opportunity Title: Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 29, 2019
Last Updated Date: Aug 29, 2019
Original Closing Date for Applications: Sep 07, 2022
Current Closing Date for Applications: Sep 07, 2022
Archive Date: Oct 13, 2022
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
County governments
Private institutions of higher education
For profit organizations other than small businesses
City or township governments
Small businesses
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider’s recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-358.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 320079 Full Announcement-PAR-19-358 -> PAR-19-358-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00254327 Sep 16, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00259766 Sep 16, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00270246 Nov 16, 2021 Sep 07, 2022 View

Package 1

Mandatory forms

320079 RR_SF424_2_0-2.0.pdf

320079 PHS398_CoverPageSupplement_4_0-4.0.pdf

320079 RR_OtherProjectInfo_1_4-1.4.pdf

320079 PerformanceSite_2_0-2.0.pdf

320079 RR_KeyPersonExpanded_2_0-2.0.pdf

320079 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

320079 RR_Budget_1_4-1.4.pdf

320079 RR_SubawardBudget30_1_4-1.4.pdf

320079 PHS398_ModularBudget_1_2-1.2.pdf

320079 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

320079 RR_SF424_2_0-2.0.pdf

320079 PHS398_CoverPageSupplement_5_0-5.0.pdf

320079 RR_OtherProjectInfo_1_4-1.4.pdf

320079 PerformanceSite_2_0-2.0.pdf

320079 RR_KeyPersonExpanded_2_0-2.0.pdf

320079 PHS398_ResearchPlan_4_0-4.0.pdf

320079 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

320079 RR_Budget_1_4-1.4.pdf

320079 RR_SubawardBudget30_1_4-1.4.pdf

320079 PHS398_ModularBudget_1_2-1.2.pdf

320079 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

320079 RR_SF424_5_0-5.0.pdf

320079 PHS398_CoverPageSupplement_5_0-5.0.pdf

320079 RR_OtherProjectInfo_1_4-1.4.pdf

320079 PerformanceSite_4_0-4.0.pdf

320079 RR_KeyPersonExpanded_4_0-4.0.pdf

320079 PHS398_ResearchPlan_4_0-4.0.pdf

320079 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

320079 RR_Budget_3_0-3.0.pdf

320079 RR_SubawardBudget30_3_0-3.0.pdf

320079 PHS398_ModularBudget_1_2-1.2.pdf

320079 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T08:43:25-05:00

Share This Post, Choose Your Platform!

About the Author: